Favipiravir Induced Acute Pancreatitis in a COVID-19 Patient

Authors

  • AHM Ejrarul Alam Khan Medical officer, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Mohammad Mahfuzul Hoque Assistant Professor, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Md Uzzwal Mallik Assistant Professor, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Kamalesh Chandra Basu Assistant Professor, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Mohammed Masudul Hasan Assistant Professor, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Imran Mahmud Registrar, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Mirza Mohammad Asif Adnan Assistant registrar, Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Md Mujibur Rahman Professor of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/jom.v22i1.51396

Keywords:

COVID-19, gastrointestinal

Abstract

There are a number of gastrointestinal symptoms and complications of COVID-19. Asymptomatic increase in pancreatic enzymes and rarely symptomatic pancreatitis are observed in this disease. This article describes a 37-year-old male suffering from mildly symptomatic COVID-19 infection, who received tablet favipiravir for his management. His condition was improving, when he developed acute pancreatitis, diagnosed clinically, biochemically and also with help of abdominal ultrasound. When he developed this, all typical symptoms of COVID-19 were improved. As a result, role of favipiravir in the development of this pancreatitis was suspected.

J MEDICINE JAN 2021; 22 (1) : 69-71

Downloads

Download data is not yet available.
Abstract
33
PDF
40

Downloads

Published

2021-01-14

How to Cite

Khan, A. E. A., Hoque, M. M., Mallik, M. U., Basu, K. C., Hasan, M. M., Mahmud, I., Adnan, M. M. A., & Rahman, M. M. (2021). Favipiravir Induced Acute Pancreatitis in a COVID-19 Patient. Journal of Medicine, 22(1), 69–71. https://doi.org/10.3329/jom.v22i1.51396

Issue

Vol. 22 No. 1 (2021)

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).